Are you looking for an intellectual sparring partner on a specific topic? We offer several options for companies wishing to engage in a research-driven corporate partnership:

Our research for your business targets several management domains as well as specific industries, and is conducted in research units such as our Centres for Excellence with a theme-based focus or our Industry Centres with a sector focus.

Explore the research formulas that can benefit your business.

  1. NEW

    Energy sector gearing up for digital transformation

    Date :

    Distribution system operators are facing a radical digital transformation of their business model. They could go from purely managing the physical infrastructure to acting as data hubs or neutral distributors of energy data as well. Are we on the verge of an ‘Uberisation’ of the energy sector? Stijn Viaene, Professor at Vlerick Business School, believes we are.

  2. “HR also needs to become more accountable”

    Date :

    Ivan De Witte and Marion Debruyne on the challenges facing HR, in response to the renewal of the Chair Partnership with Hudson: “An HR manager who wants to be future-proof can learn from his or her counterpart in Finance, the CFO, who was forced to stop navel-gazing some time ago. After all, HR shares the need to become more accountable.”

  3. The new insurance: ready to plug & play?

    Date :

    Digital transformation affects insurance as well. Insurers have to reinvent themselves and become a whole lot sexier. Bjorn Cumps, Professor of Digital Banking, comments on the main findings of research conducted by Chair Partner Accenture.

  4. Innovative cancer treatments: how much are we willing to pay?

    Date :

    One man in three and one woman in four will develop cancer before their 75th birthday. In Belgium, cancer is the second major cause of disease burden after cardiovascular diseases and it is unlikely this will change in the foreseeable future. Increasingly better but more expensive cancer therapies are becoming available. Needless to say, in these times of austerity, the public budget for cancer treatment is under pressure. How can we ensure all patients continue to have access to these expensive but potentially life-saving medicines at a price society can afford, while at the same time encouraging pharmaceutical companies to innovate?

Interested in becoming a partner?

For more information contact Maureen O’Hare, Corporate Development Manager
Maureen.ohare@vlerick .com
+32 476 66 76 61

Accreditations
& Rankings

Equis Association of MBAs AACSB Financial Times